Reuters
Reuters
@Reuters·4.2M subscribers·86.9K videos

Obesity drug maker Novo Nordisk lifts outlook again | REUTERS

Posted

May 2, 2024

Views

937

Likes

6

Engagement

0.64%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Novo Nordisk raised its 2024 outlook and delivered better-than-expected first-quarter profits as the Danish drugmaker races to boost output of its Wegovy weight-loss drug and fend off competition from rival Eli Lilly.

#News #novonordisk #wegovy #earnings #health #Reuters #Newsfeed

Read the story here

👉 Subscribe

Keep up with the latest news from around the world

Follow Reuters on Facebook

Follow Reuters on Twitter

Follow Reuters on Instagram

Guests & Subjects Covered

Novo NordiskEli Lilly NewsReuters Newsfeed ReadSubscribe KeepFollow ReutersFacebook Follow ReutersTwitter Follow Reuters

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Obesity drug maker Novo Nordisk lifts outlook again | REUTERS · Reuters · Sentinel